Samil Pharmaceutical Co.,Ltd
KRX:000520.KS
13230 (KRW) • At close February 5, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 196,345.808 | 179,676.108 | 134,246.778 | 122,998.992 | 121,107.086 | 94,599.866 | 92,037.815 | 96,758.066 | 88,136.459 | 85,460.673 | 89,228.924 | 91,444.317 | 94,475.808 | 98,333.934 | 115,949.87 | 125,514.432 | 104,901.18 |
| Kosten van de omzet
| 124,134.178 | 112,190.589 | 85,258.535 | 73,966.763 | 74,382.89 | 59,808.845 | 51,132.624 | 55,307.895 | 50,788.187 | 51,485.763 | 53,094.808 | 53,682.165 | 56,341.633 | 54,946.656 | 78,181.625 | 69,771.864 | 56,154.55 |
| Brutowinst
| 72,211.63 | 67,485.52 | 48,988.243 | 49,032.229 | 46,724.196 | 34,791.021 | 40,905.191 | 41,450.17 | 37,348.272 | 33,974.91 | 36,134.116 | 37,762.152 | 38,134.175 | 43,387.278 | 37,768.245 | 55,742.568 | 48,746.63 |
| Brutowinstmarge
| 0.368 | 0.376 | 0.365 | 0.399 | 0.386 | 0.368 | 0.444 | 0.428 | 0.424 | 0.398 | 0.405 | 0.413 | 0.404 | 0.441 | 0.326 | 0.444 | 0.465 |
| Onderzoek- en ontwikkelingskosten
| 5,600.898 | 2,907.131 | 2,971.491 | 3,007.248 | 3,059.615 | 2,181.544 | 1,961.02 | 1,254.449 | 1,119.058 | 2,789.829 | 2,045.566 | 2,829.516 | 3,821.943 | 4,615.668 | 5,688.922 | 4,540.776 | 2,359.651 |
| Algemene en administratieve kosten
| 14,689.395 | 10,382.083 | 7,552.696 | 6,069.818 | 7,709.602 | 8,734.533 | 4,664.153 | 4,573.129 | 4,321.269 | 3,665.749 | 3,472.736 | 3,138.182 | 3,603.093 | 3,732.962 | 4,583.408 | 5,206.882 | 4,042.454 |
| Verkoop- en marketingkosten
| 16,609.697 | 18,793.977 | 12,179.904 | 10,024.812 | 9,249.334 | 10,149.692 | 13,842.091 | 12,838.913 | 12,033.63 | 15,767.317 | 14,231.079 | 14,784.84 | 17,741.835 | 14,807.94 | 17,379.581 | 20,045.065 | 17,003.565 |
| Verkoop-, algemene en administratieve kosten
| 31,299.092 | 29,176.06 | 19,732.6 | 16,094.63 | 16,958.936 | 18,884.225 | 18,506.244 | 17,412.042 | 16,354.899 | 19,433.066 | 17,703.815 | 17,923.022 | 21,344.928 | 18,540.902 | 21,962.989 | 25,251.947 | 21,046.019 |
| Overige kosten
| 30,699.777 | 31,385.747 | 25,884.411 | 23,391.953 | 21,882.805 | 19,457.042 | -11.295 | -418.903 | -106.606 | -1,231.069 | -939.966 | -255.162 | 6 | 278.596 | 264.755 | -476.394 | -1,467.611 |
| Bedrijfskosten
| 65,751.603 | 63,468.938 | 48,588.502 | 42,493.831 | 41,901.356 | 40,522.811 | 39,598.176 | 37,596.88 | 35,745.886 | 42,590.486 | 38,112.781 | 39,337.379 | 46,899.647 | 42,837.281 | 48,890.191 | 48,521.936 | 37,917.932 |
| Bedrijfsresultaat
| 6,471.028 | 4,016.582 | 1,054.828 | 6,538.398 | 4,822.839 | -5,731.79 | 1,307.015 | 3,853.289 | 1,602.388 | -8,615.577 | -1,978.664 | -1,575.227 | -6,959.681 | 549.993 | -11,121.945 | 7,220.633 | 10,828.7 |
| Bedrijfsresultaat ratio
| 0.033 | 0.022 | 0.008 | 0.053 | 0.04 | -0.061 | 0.014 | 0.04 | 0.018 | -0.101 | -0.022 | -0.017 | -0.074 | 0.006 | -0.096 | 0.058 | 0.103 |
| Totaal overige inkomsten en kosten netto
| -5,047.247 | -5,001.24 | -5,816.184 | -5,340.339 | -3,367.234 | -2,403.346 | -2,018.616 | -1,185.063 | -549.093 | -1,601.514 | 14,205.654 | -1,475.603 | 1,049.195 | 2,812.483 | 20,540.545 | -1,720.277 | -586.841 |
| Inkomen voor belasting
| 1,423.781 | 1,058.097 | -4,761.356 | 1,198.059 | 1,455.605 | -8,135.136 | -711.601 | 2,668.227 | 1,053.296 | -10,217.091 | 12,226.989 | -3,050.83 | -7,975.168 | 3,362.476 | 9,418.6 | 5,500.356 | 10,241.859 |
| Inkomen voor belasting ratio
| 0.007 | 0.006 | -0.035 | 0.01 | 0.012 | -0.086 | -0.008 | 0.028 | 0.012 | -0.12 | 0.137 | -0.033 | -0.084 | 0.034 | 0.081 | 0.044 | 0.098 |
| Belastingkosten
| -239.758 | 1,086.384 | 585.307 | -142.504 | 669.347 | 427.612 | 554.964 | 1,781.624 | 464.926 | 972.444 | 4,296.957 | -151.001 | -1,196.448 | 1,318.152 | 2,354.769 | 3,751.862 | 4,702.039 |
| Nettowinst
| 1,663.54 | -28.287 | -5,346.663 | 1,340.564 | 786.258 | -8,562.748 | -1,266.565 | 886.603 | 588.369 | -11,189.534 | 7,930.032 | -2,899.829 | -6,778.721 | 2,044.324 | 7,063.831 | 1,748.494 | 5,539.82 |
| Nettowinstmarge
| 0.008 | -0 | -0.04 | 0.011 | 0.006 | -0.091 | -0.014 | 0.009 | 0.007 | -0.131 | 0.089 | -0.032 | -0.072 | 0.021 | 0.061 | 0.014 | 0.053 |
| WPA (Winst Per Aandeel)
| 116.16 | -2.03 | -386.63 | 99.7 | 58.55 | -736.85 | -109.01 | 76.43 | 50.51 | -954.48 | 668.09 | -244.22 | -571.11 | 171.31 | 574.1 | 139.68 | 442.32 |
| Verwaterde WPA
| 115.37 | -2.03 | -386.63 | 99.7 | 58.55 | -736.82 | -108.93 | 76.43 | 50.51 | -954.48 | 668.09 | -244.22 | -571.11 | 171.31 | 574.1 | 139.68 | 442.32 |
| EBITDA
| 10,335.814 | 10,309.553 | 5,111.637 | 11,324.062 | 8,811.817 | -2,054.29 | 4,949.69 | 6,764.803 | 4,641.823 | -5,423.141 | 1,549.74 | 735.531 | -2,371.765 | 8,831.815 | 15,121.755 | 10,578.775 | 13,335.166 |
| EBITDA ratio
| 0.053 | 0.054 | 0.043 | 0.091 | 0.079 | -0.02 | 0.052 | 0.072 | 0.055 | -0.066 | 0.195 | 0.028 | -0.031 | 0.083 | 0.127 | 0.085 | 0.122 |